During the past decade, Ospedale Antonio Perrino; Oncologia Medica conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Antonio Perrino; Oncologia Medica" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Gruppo Oncologico Italiano di Ricerca Clinica" with 3 trials sponsored, "Canadian Cancer Trials Group" with 2 trials sponsored, "National Cancer Institute, Naples" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Antonio Perrino; Oncologia Medica" #1 collaborator was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Istituto Toscano Tumori" with 2 trials as a collaborator, "Mipharm S.p.A." with 2 trials as a collaborator, "Temas srl" with 2 trials as a collaborator and "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Antonio Perrino; Oncologia Medica" are "Breast Cancer" (6 trials), "Ovarian Cancer" (2 trials), "Small Cell Lung Cancer" (2 trials), "Basal Cell Carcinoma" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Ospedale Antonio Perrino; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ospedale Antonio Perrino; Oncologia Medica" are "Drug" (16 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Pertuzumab" (4 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Antonio Perrino; Oncologia Medica" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Antonio Perrino; Oncologia Medica". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ospedale Antonio Perrino; Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Antonio Perrino; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".